Loading
CVS Group plc Stock: price and insider trades · United Kingdom
4 insiders bought €116k of shares over the last 90 days, the latest filed 24 Sept 2026.
CVS Group plc: what insiders have been doing
CVS Group plc is a listed company. Filings by its managers are published through RNS (LSE). 5 insiders have disclosed 5 filings since 18 October 2025.
Not one open-market sale was filed. On the buying side, 5 insiders reported 5 purchases totalling €146k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 3 board members, 1 finance chief and 1 senior executive. At €58k, the purchase published on 24 September 2026 by Laura Hagan is the largest of the period (0.0061% of market cap).
In the case of 2 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The last purchase on record was published on 24 September 2026, which is 24 days ago. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (UK MAR).
Across the 833 companies tracked on its exchange, the median is 6 filings; at 5 filings, this issuer sits below that mark. Our records for CVS Group plc go back to 2024, with 11 purchases and no sales on the open market in total.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€256,490
11 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleDavid Wilton2 buys
Joanne Shaw2 buys
Laura Hagan1 buy
Richard Fairman1 buy
Richard Gray1 buy
Robin Alfonso1 buy
Since the insiders bought
- -0.8%Entry £13.07 · Close at T+30 £12.97
- +1.0%Entry £12.90 · Close at T+30 £13.03
- +2.9%Entry £12.90 · Close at T+30 £13.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate CVS Group plc Buy (bullish), based on 11 analysts. Average price target: £16.26.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 14,183 of 24,148 companies
46.4
score / 100
Value49
Quality44
FCF yld3.0%
Earn yld0.8%
EV/EBITDA10.6x
ROE6.0%
Gross mgn42%
Net mgn1.0%
Debt/EBITDA2.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
£11.83
Analyst consensus
11 analystsBuy
£12.50Target £16.26(+37%)£20.00
Income statement
Revenue£638.7M
Gross profit£268.7M42% margin
EBITDA£105.4M17% margin
Net income£6.4M2.4% margin
Valuation
PER (trailing)49.3x
PER (forward)1144.7x
P/Book287.1x
Beta1.09
Balance sheet & cash
Market cap£797M
Total debt£287.8M
Free Cash Flow£24.7M
Debt / Equity108%
Profitability & ownership
ROE6.0%
ROA4.2%
% insiders0.7%
% institutions79.2%
Last declaration on 24 September 2026
Declarations11 total
4,128 shares@ £12.17820.0061% mcap100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B2863827RNS:9790044
Canonical exit: 23 Dec 2026 (T+90)
1,592 shares@ £12.8660.0025% mcap99.4% of flowLondon Stock Exchange (XLON)ISIN GB00B2863827RNS:9716189
Canonical exit: 8 Nov 2026 (T+90)
768 shares@ £12.94270.0012% mcap100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B2863827RNS:9709233
Canonical exit: 4 Nov 2026 (T+90)
1,500 shares@ £12.75880.0023% mcap32.7% of flowLondon Stock Exchange (XLON)ISIN GB00B2863827RNS:9706988
Canonical exit: 2 Nov 2026 (T+90)
2,000 shares@ £12.7696100.0% of flowLondon Stock Exchange - AIM (XLON)ISIN GB00B2863827RNS:5fac30e5-f14c-4608-b7ac-a8f2a4063474
Canonical exit: 5 Apr 2026 (T+90)
1,644 shares@ £12.16100.0% of flowLondon Stock Exchange - AIM (XLON)ISIN GB00B2863827RNS:5735483
Canonical exit: 9 Oct 2025 (T+90)
1,000 shares@ £12.47621.6% of flowLondon Stock Exchange - AIM (XLON)ISIN GB00B2863827RNS:5678009
Canonical exit: 31 Aug 2025 (T+90)
14 shares@ £8.40290.6% of flowLondon Stock Exchange - AIM (XLON)ISIN GB00B2863827RNS:5490617
Canonical exit: 27 Feb 2025 (T+90)
1,004 shares@ £10.19100.0% of flowLondon Stock Exchange - AIM (XLON)ISIN GB00B2863827RNS:5243049-2
Canonical exit: 25 Sept 2024 (T+90)
2,500 shares@ £10.5245.6% of flowLondon Stock Exchange - AIM (XLON)ISIN GB00B2863827RNS:5243049-0
Canonical exit: 23 Sept 2024 (T+90)
2,440 shares@ £10.24100.0% of flowLondon Stock Exchange - AIM (XLON)ISIN GB00B2863827RNS:5243049-1
Canonical exit: 24 Sept 2024 (T+90)
11 of 11 declarations
About CVS Group plc
CVS Group plc is a UK-based company specializing in veterinary services and pet product sales. It operates through a network of veterinary clinics and pet stores.
